Suven Life Sciences announces positive topline results from Phase-2 PoC signal detection open label study of Ropanicant
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
Subscribe To Our Newsletter & Stay Updated